-
Oncology
People without health insurance and those on Medicaid are more likely to be diagnosed with advanced stages of cancer than those with private health insurance, ACS researchers report.
American Cancer Society - Tue, 12 June 2007
http://www.cancer.org/
-
Oncology
A new study shows the drug Nexavar helps people with advanced liver cancer live longer.
American Cancer Society - Tue, 12 June 2007
http://www.cancer.org/
-
Oncology
Johns Hopkins researchers have found a way to directly observe cell migration - in real time and in living tissue. The scientists say their advance could lead to strategies for controlling both normal growth and the spread of cancer, processes that depend on the programmed, organized movement of cells across space.
Johns Hopkins Hospital - Tue, 12 June 2007
http://www.hopkinshospital.org
-
Psychiatry
A study suggests that in older persons without manifest cognitive impairment, a higher level of chronic psychologic distress is associated with increased incidence of mild cognitive impairment.
Medscape - Tue, 12 June 2007
http://www.medscape.com
-
Orthopaedics
In a randomized trial of patients aged 5 to 18 years with ankle injuries, a removable ankle brace was more effective in recovery of physical function than a below-knee walking cast.
Medscape - Tue, 12 June 2007
http://www.medscape.com
-
Infectious Diseases
In a study of patients who could not produce adequate expectorate, use of 3 sputum samples was more sensitive for tuberculosis diagnosis than was gastric washing.
Medscape - Tue, 12 June 2007
http://www.medscape.com
-
Oncology
The use of mitotane after radical resection was found to significantly increase both disease-free and overall survival in patients with adrenocortical carcinoma.
Medscape - Tue, 12 June 2007
http://www.medscape.com
-
Oncology
The first effective systemic treatment for advanced liver cancer reportedly extends survival by 44% and is expected to revolutionize future clinical trials in this area.
Medscape - Tue, 12 June 2007
http://www.medscape.com
-
Rheumatology
NICE is currently appraising adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis. Following publication of the final appraisal determination (FAD) in November 2006, appeals were received from Abbot Laboratories Ltd, Arthritis and Musculoskeletal Alliance (ARMA), National Rheumatoid Arthritis Society (NRAS), Royal College of Nursing (RCN), Schering-Plough Ltd and Wyeth Pharmaceuticals.
National Institute for Health and Clinical Excellence - Tue, 12 June 2007
http://www.nice.org.uk
-
Immunology
The Meningitis Vaccine Project (MVP) today released new data on the performance of a meningitis vaccine in West African children, suggesting that the new vaccine—expected to sell initially for 40 US cents a dose—will be much more effective in protecting African children and their communities than any vaccine currently on the market in the region.
World Health Organization - Tue, 12 June 2007
http://www.who.int